Baiyun Mountain Zhi in the World 500 strong Wanglaoji hope sales 15 billion yuan

On the morning of September 18, nearly 30 individual investors came to Guangzhou Baiyun Mountain Pharmaceutical Group Co., Ltd. (600332), which was organized by Shanghai Stock Exchange to conduct on-site research, which is the theme of "I am a shareholder, a small investor into Baiyun Mountain". According to the relevant person in charge of the Shanghai Stock Exchange, the company carried out "I am a shareholder" series of activities, aimed at further guiding and standardizing the investor relationship management of listed companies, protecting the legitimate rights and interests of investors, especially small and medium-sized investors, and promoting investors to establish shareholder awareness and constantly enhance their exercise of shareholder Prior to this, the "I am a shareholder" series has visited 11 High-profile listed companies, including Pudong Hair Bank, Tongren temple and other well-known enterprises, this event for the first time to enter the Guangdong listed companies. And according to the vast number of small and medium-sized investors in the online voting situation, Canton Medicine Baiyun Mountain in the season to stand out in the audition. Investor hot hold "Baiyun Mountain" meeting, the Dong Yun of Baiyun Mountain led the investor to visit the product exhibition exhibition. On the side of the development of Baiyun Mountain and development prospects, while answering investors concern and various issues. According to the introduction, Guang-Yao Baiyun Mountain existing "Wang Lao Ji", "Chen Lizi" and other 13 "Old Chinese" enterprises, the current "Baiyun Mountain" brand value of up to 28.3 billion yuan, is currently published in the pharmaceutical industry the highest value brand, but also in the pharmaceutical brands of many drugs in the development of the best national brand. At present, the pharmaceutical enterprises of Guangzhou Baiyun Mountain have been crowned and use the Baiyun Mountain brand, will make full use of the "Baiyun Mountain" of the national advantages to further develop the foreign market. Wang Old Kat Herbal tea is expected to sell 15 billion yuan in the exchange with investors, Canton Pharmaceutical group Kong Li Chuyuan introduced the future development strategy of Baiyun Mountain, the company management on the overall listing of the group, the company's operating performance, Wang old Kat sales channels, Yaan production base construction, the company's development strategy, Stock price performance and other issues with the presence of investors have in-depth interactive exchanges. At the meeting, some investors paid particular attention to the health of Wang Old Jida's current business and development. Wang Wu Changhai, chairman of the health industry at the old Jida, said: "Although the sales cost of Wanglaoji this year, but this is in the herbal tea market fierce competition must be carried out, and in the first half of this year we have seen in the investment returns." Since this year, Wang Old Kat developed rapidly, especially the sugar-free old Kat, Wang Old Kat herbal tea, such as solid drink after the introduction of new products, widely popular market. At present, Wanglaoji has been in the world more than 50 countries and regions for trademark registration, products exported to 20 countries and regions. In order to further promote the herbal tea industry internationalization and the Wang Old Kat brand to the world, Guangzhou Medical Research General Hospital Dean (Wealth court), Nobel laureate, viagra father Murad, has signed with Swiss SGS, will work together to study international tea. The company next will be from new product research and development, capacity layout, marketing network and terminal market, cost control and so on to increase the strength, further excavation "Wang Lao Ji" and other brands of resource power. This year Wang Old Kat Herbal tea in accordance with the rapid elimination caliber, is expected to achieve 15 billion yuan sales. There are investors concernedThe development of the therapeutic double plasmid HBV DNA vaccine and the strategy of multi-brand developing of the broad-spectrum medicine Baiyun Mountain. According to the introduction, Guang-Yun Baiyun Mountain is the development of therapeutic dual-plasmid HBV DNA vaccine as a therapeutic hepatitis B vaccine, at present Phase II Stage B Clinical research progress smoothly, all subjects have completed clinical trials. Baiyun Mountain Zhi in the world's top 500 after the reorganization of Baiyun Mountain, the first report of the disclosure of data shows that the January-June Kwong Yun Baiyun operating income of 9.072 billion yuan, the same period increased by 60.58%; The net profit of the shareholders of the listed company is 587 million yuan, the increase of 37.4%. Company management said: The reorganization of the completion of the work, to the canton of Baiyun Mountain brought a comprehensive resource integration opportunities, the company will further strengthen the integration of the operation, the layout of the national market, around the revitalization of the South Medicine, the development of health and the promotion of large business, the three plates went hand in hand Li Chuyuan, chairman of Guang-medicine Baiyun Mountain, said in the next few years, Guang-medicine Baiyun Mountain will implement industry, assets and talent three major upgrades, in the big South Pharmaceutical plate from marketing-oriented to technological innovation, in the big health plate, from Wang Old Kat herbal tea-oriented manufacturing manufacturing industry, health management, health care, Health care, such as large healthy industrial complex upgrade, in the large commercial sector, from regional leading to the national giants upgrade. Rain）